Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 27 October 2022, 18:04 HKT/SGT
Share:
    

Source: Eminence Business Media
Watch the Biggest T10 Indian Pharma Championship on VOOT live

MUMBAI, INDIA, Oct 27, 2022 - (ACN Newswire) - Keeping the spirit of cricket in mind, Eminence Business Media is proud to announce T10 Indian Pharma Champions Trophy 2022 scheduled for December 1-7, 2022, in Mumbai. Managing Director of Eminence Business Media, Ms. Guneet Kaur Hayer, believes that cricket is not just a sport for many; it is an emotion and as a company they want people to take a short rejuvenating break from their tiring work, and to do something that works for their physical health, mental health, and fitness at par. She also said it is every company's responsibility to keep their employees healthy, fit, engaged, appreciated and happy with their jobs.


For the first time ever, a cricket league of such a high stature has been announce exclusively for the Pharmaceutical Industry that would make an enduring impact on people's lives. It provides great entertainment, teaches important skills; physical, mental, and social.

What's in It for the Pharma Teams?
1. Winning prize money for up to INR 25 Lakhs.
2. Live streaming gives that celebrity vibe to show your talent on the screen to 20 million viewers.
3. Four-wheeler, two wheelers and several other remunerative awards for Man of the Series, Man of the Matches, Purple Hat, Orange Hat Winners and more.
4. Win gadgets like Laptops, mobiles and more.
5. Best of all is the joy of playing cricket and winning the championship.
6. Support NGO by participating, or partnering, where in part percentage will go in donation to them.

What's in It for the Sponsors?
1. Exclusive Brand Positioning & Visibility.
2. Exclusive marketing
3. Live streaming on VOOT across the nation.
4. On air campaigns in multiple cities.
5. Network and enhance your market reach.
6. Pre- scheduled meetings.
7. Support NGO by participating, or partnering, where in part percentage will go in donation to them.


Topic: Press release summary
Source: Eminence Business Media


http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
CTO Confidence in Scaling AI Falls for Third Straight Year, Akkodis Report Finds  
June 23, 2026 12:45 HKT/SGT
JCB Contactless Expands to Metro de Madrid Enabling Seamless Tap-to-Ride Access Across the Network  
Tuesday, June 23, 2026 11:00:00 AM
Anker Innovations announces the listing plan on the Main Board of HKEX with a maximum fundraising of HK$4,631.6 Million*  
June 23, 2026 10:11 HKT/SGT
WINS Acquires Control of 5 Newbuilt DP Crew Transfer Vessels Through Acquisition of Controlling Stake in Fast Offshore Supply Pte Ltd  
June 23, 2026 09:49 HKT/SGT
Kaspersky signs agreement with LIVA Telecom to integrate cybersecurity solutions into Australian residential and business connectivity plans  
June 23, 2026 09:00 HKT/SGT
JBM Healthcare Announces FY2026 Annual Results  
June 22, 2026 22:47 HKT/SGT
CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the World's First Bispecific Antibody for Passive Immunization Against Rabies  
June 22, 2026 19:00 HKT/SGT
Radisson Continues to Extend Scope of Gold Mineralization at the O'Brien Gold Project with Latest Drill Results  
June 22, 2026 18:59 HKT/SGT
Focus Graphite Announces SEDAR+ Filing of the NI 43-101 Technical Report with the Updated Mineral Resource for the Lac Tetepisca Project  
June 22, 2026 17:29 HKT/SGT
Shenzhen HQVT Technology Lists on HKEX Main Board, Accelerating Implementation of Multispectral AI Technology  
June 22, 2026 15:21 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: